What: Galena Biopharma (NASDAQ: GALE) was up 18% at 1:20 p.m. EDT after announcing this morning that the Food and Drug Administration gave a Fast Track designation to the biotech’s NeuVax breast cancer drug.
What: Galena Biopharma (NASDAQ: GALE) was up 18% at 1:20 p.m. EDT after announcing this morning that the Food and Drug Administration gave a Fast Track designation to the biotech’s NeuVax breast cancer drug.